PMVP PMV Pharmaceuticals, Inc.

NASDAQ
$1.33

PMV Pharmaceuticals, Inc. (PMVP) is expected to report earnings on November 13, 2026, before the market open. The consensus earnings estimate is a loss of $0.31 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +8.1% since its last earnings release on August 14, 2026.

PMV Pharmaceuticals Beat Consensus Estimates
Friday, August 14, 2026 · 8:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 13
Friday · 8:00 AM ET
Earnings Whisper
-
vs ($0.31)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.34

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About PMV Pharmaceuticals, Inc.

PMV Pharma is a clinical-stage oncology company pioneering the discovery and development of small molecule therapies designed to activate p53 function.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.